News from the world

13

May

Deal on tackling EU shortages of essential medicines

  • Prioritise investment in EU manufacturing capacity to increase autonomy

  • “Buy European” approach to support EU production

  • Stimulate collaborative procurement

  • Covers medicines such as antibiotics, insulin, and vaccines, and medicines for chronic and rare diseases

17

Jul

Inside Pharma’s Push for More Resilient Supply Chains

Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing,...

17

Jul

US FDA CDER plans new guidance on AI, electronic safety report submissions, and more

The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has...

16

Jul

EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health

DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry...

15

Jul

Riforma farmaceutica. Via libera della Commissione Sanità del Senato

 Le poche modifiche approvate non cambiano l'impianto della riforma. L’articolo 3 a...